Artificial intelligence and pathology: from principles to practice and future applications in histomorphology and molecular profiling

A Stenzinger, M Alber, M Allgäuer, P Jurmeister… - Seminars in cancer …, 2022 - Elsevier
The complexity of diagnostic (surgical) pathology has increased substantially over the last
decades with respect to histomorphological and molecular profiling. Pathology has steadily …

Computational drug discovery for castration-resistant prostate cancers through in vitro drug response modeling

W Zhang, AM Lee, S Jena, Y Huang… - Proceedings of the …, 2023 - National Acad Sciences
Prostate cancer (PC) is the most frequently diagnosed malignancy and a leading cause of
cancer deaths in US men. Many PC cases metastasize and develop resistance to systemic …

[HTML][HTML] Predicting COVID-19 disease progression and patient outcomes based on temporal deep learning

C Sun, S Hong, M Song, H Li, Z Wang - BMC Medical Informatics and …, 2021 - Springer
Background The coronavirus disease 2019 (COVID-19) pandemic has caused health
concerns worldwide since December 2019. From the beginning of infection, patients will …

[HTML][HTML] Deep learning methods for drug response prediction in cancer: predominant and emerging trends

A Partin, TS Brettin, Y Zhu, O Narykov, A Clyde… - Frontiers in …, 2023 - frontiersin.org
Cancer claims millions of lives yearly worldwide. While many therapies have been made
available in recent years, by in large cancer remains unsolved. Exploiting computational …

A cross-study analysis of drug response prediction in cancer cell lines

F Xia, J Allen, P Balaprakash, T Brettin… - Briefings in …, 2022 - academic.oup.com
To enable personalized cancer treatment, machine learning models have been developed
to predict drug response as a function of tumor and drug features. However, most algorithm …

Predicting cancer drug response using parallel heterogeneous graph convolutional networks with neighborhood interactions

W Peng, H Liu, W Dai, N Yu, J Wang - Bioinformatics, 2022 - academic.oup.com
Motivation Due to cancer heterogeneity, the therapeutic effect may not be the same when a
cohort of patients of the same cancer type receive the same treatment. The anticancer drug …

[HTML][HTML] Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning

AC de Jong, A Danyi, J van Riet, R de Wit… - Nature …, 2023 - nature.com
Response to androgen receptor signaling inhibitors (ARSI) varies widely in metastatic
castration resistant prostate cancer (mCRPC). To improve treatment guidance, biomarkers …

Trends and potential of machine learning and deep learning in drug study at single-cell level

R Qi, Q Zou - Research, 2023 - spj.science.org
Cancer treatments always face challenging problems, particularly drug resistance due to
tumor cell heterogeneity. The existing datasets include the relationship between gene …

A framework for integrating artificial intelligence for clinical care with continuous therapeutic monitoring

E Chen, S Prakash, V Janapa Reddi, D Kim… - Nature Biomedical …, 2023 - nature.com
The complex relationships between continuously monitored health signals and therapeutic
regimens can be modelled via machine learning. However, the clinical implementation of …

Machine learning in the identification, prediction and exploration of environmental toxicology: Challenges and perspectives

X Wu, Q Zhou, L Mu, X Hu - Journal of Hazardous Materials, 2022 - Elsevier
Over the past few decades, data-driven machine learning (ML) has distinguished itself from
hypothesis-driven studies and has recently received much attention in environmental …